(RYI) Ryerson Holding - Overview
Stock: Carbon Steel, Stainless Steel, Aluminum, Alloy, Nickel
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.25% |
| Yield on Cost 5y | 5.99% |
| Yield CAGR 5y | 46.11% |
| Payout Consistency | 99.2% |
| Payout Ratio | 118.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 44.2% |
| Relative Tail Risk | -4.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 19.85 |
| Character TTM | |
|---|---|
| Beta | 0.988 |
| Beta Downside | 0.760 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.17% |
| CAGR/Max DD | -0.09 |
Description: RYI Ryerson Holding December 25, 2025
Ryerson Holding Corp (NYSE:RYI) is a Chicago-based processor and distributor of industrial metals, offering carbon steel, stainless steel, alloy steels, aluminum, nickel and other “red” metals in forms such as coils, sheets, bars, plates, structural shapes and tubing, plus value-added processing services.
The company supplies a broad spectrum of end-markets-including metal fabrication, industrial machinery, transportation equipment, HVAC, food-processing, construction gear and oil-&-gas-leveraging a nationwide network of service centers and a global sourcing platform.
Key operating metrics (FY 2023): revenue ≈ $5.0 bn, adjusted EBITDA margin ≈ 9.5%, and inventory turnover ≈ 4.2×, reflecting a modest improvement over the prior year as steel prices stabilized after the 2022-23 price surge. The sector’s near-term outlook is driven by U.S. construction activity (housing starts up 6% YoY in Q3 2024) and the resurgence of manufacturing output (PMI hovering around 52), both of which sustain demand for specialty steel and processing services.
Given Ryerson’s exposure to cyclical industrial demand and its relatively thin pricing spread, analysts should monitor raw-material cost volatility (e.g., coking coal and iron-ore price indices) and the firm’s ability to pass through price changes without eroding margins.
For a deeper quantitative dive into Ryerson’s valuation dynamics, you might explore the ValueRay platform’s sector-specific models and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -22.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.50 > 1.0 |
| NWC/Revenue: 14.45% < 20% (prev 15.23%; Δ -0.78% < -1%) |
| CFO/TA 0.03 > 3% & CFO 66.5m > Net Income -22.8m |
| Net Debt (826.8m) to EBITDA (90.5m): 9.14 < 3 |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.2m) vs 12m ago -1.75% < -2% |
| Gross Margin: 17.98% > 18% (prev 0.19%; Δ 1779 % > 0.5%) |
| Asset Turnover: 178.1% > 50% (prev 185.7%; Δ -7.55% > 0%) |
| Interest Coverage Ratio: 0.23 > 6 (EBITDA TTM 90.5m / Interest Expense TTM 39.5m) |
Altman Z'' 3.07
| A: 0.26 (Total Current Assets 1.30b - Total Current Liabilities 656.9m) / Total Assets 2.49b |
| B: 0.30 (Retained Earnings 742.8m / Total Assets 2.49b) |
| C: 0.00 (EBIT TTM 9.00m / Avg Total Assets 2.51b) |
| D: 0.35 (Book Value of Equity 594.4m / Total Liabilities 1.69b) |
| Altman-Z'' Score: 3.07 = A |
Beneish M -2.96
| DSRI: 1.10 (Receivables 520.9m/499.7m, Revenue 4.47b/4.70b) |
| GMI: 1.05 (GM 17.98% / 18.93%) |
| AQI: 1.02 (AQ_t 0.10 / AQ_t-1 0.10) |
| SGI: 0.95 (Revenue 4.47b / 4.70b) |
| TATA: -0.04 (NI -22.8m - CFO 66.5m) / TA 2.49b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of RYI shares?
Over the past week, the price has changed by +6.09%, over one month by +13.75%, over three months by +47.14% and over the past year by +38.02%.
Is RYI a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RYI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29 | -3.1% |
| Analysts Target Price | 29 | -3.1% |
| ValueRay Target Price | 31.4 | 5% |
RYI Fundamental Data Overview January 31, 2026
P/B = 1.1546
P/EG = 0.35
Revenue TTM = 4.47b USD
EBIT TTM = 9.00m USD
EBITDA TTM = 90.5m USD
Long Term Debt = 498.2m USD (from longTermDebt, last quarter)
Short Term Debt = 34.7m USD (from shortTermDebt, last quarter)
Debt = 856.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 826.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.73b USD (904.2m + Debt 856.6m - CCE 29.8m)
Interest Coverage Ratio = 0.23 (Ebit TTM 9.00m / Interest Expense TTM 39.5m)
EV/FCF = 140.7x (Enterprise Value 1.73b / FCF TTM 12.3m)
FCF Yield = 0.71% (FCF TTM 12.3m / Enterprise Value 1.73b)
FCF Margin = 0.27% (FCF TTM 12.3m / Revenue TTM 4.47b)
Net Margin = -0.51% (Net Income TTM -22.8m / Revenue TTM 4.47b)
Gross Margin = 17.98% ((Revenue TTM 4.47b - Cost of Revenue TTM 3.67b) / Revenue TTM)
Gross Margin QoQ = 17.18% (prev 17.91%)
Tobins Q-Ratio = 0.70 (Enterprise Value 1.73b / Total Assets 2.49b)
Interest Expense / Debt = 1.18% (Interest Expense 10.1m / Debt 856.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = 7.11m (EBIT 9.00m * (1 - 21.00%))
Current Ratio = 1.98 (Total Current Assets 1.30b / Total Current Liabilities 656.9m)
Debt / Equity = 1.09 (Debt 856.6m / totalStockholderEquity, last quarter 787.3m)
Debt / EBITDA = 9.14 (Net Debt 826.8m / EBITDA 90.5m)
Debt / FCF = 67.22 (Net Debt 826.8m / FCF TTM 12.3m)
Total Stockholder Equity = 804.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.91% (Net Income -22.8m / Total Assets 2.49b)
RoE = -2.83% (Net Income TTM -22.8m / Total Stockholder Equity 804.5m)
RoCE = 0.69% (EBIT 9.00m / Capital Employed (Equity 804.5m + L.T.Debt 498.2m))
RoIC = 0.55% (NOPAT 7.11m / Invested Capital 1.30b)
WACC = 5.36% (E(904.2m)/V(1.76b) * Re(9.56%) + D(856.6m)/V(1.76b) * Rd(1.18%) * (1-Tc(0.21)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.71%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈47.9m ; Y1≈31.4m ; Y5≈14.3m
Fair Price DCF = N/A (negative equity: EV 457.1m - Net Debt 826.8m = -369.7m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -74.05 | EPS CAGR: -40.60% | SUE: 0.24 | # QB: 0
Revenue Correlation: -85.79 | Revenue CAGR: -7.15% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.49 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.31 | Chg30d=-0.035 | Revisions Net=+0 | Growth EPS=+277.0% | Growth Revenue=+9.1%